BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 29436707)

  • 21. Genomic profiling of brain metastases: current knowledge and new frontiers.
    Neagu MR; Gill CM; Batchelor TT; Brastianos PK
    Chin Clin Oncol; 2015 Jun; 4(2):22. PubMed ID: 26112808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Implications of Cancer Genomics: A Call for Papers.
    PLOS Medicine Editors
    PLoS Med; 2016 Apr; 13(4):e1002016. PubMed ID: 27116432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers.
    Ow TJ; Sandulache VC; Skinner HD; Myers JN
    Cancer; 2013 Nov; 119(22):3914-28. PubMed ID: 24037788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
    Patel LR; Nykter M; Chen K; Zhang W
    Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular basis of breast cancer pathological phenotypes.
    Heng YJ; Lester SC; Tse GM; Factor RE; Allison KH; Collins LC; Chen YY; Jensen KC; Johnson NB; Jeong JC; Punjabi R; Shin SJ; Singh K; Krings G; Eberhard DA; Tan PH; Korski K; Waldman FM; Gutman DA; Sanders M; Reis-Filho JS; Flanagan SR; Gendoo DM; Chen GM; Haibe-Kains B; Ciriello G; Hoadley KA; Perou CM; Beck AH
    J Pathol; 2017 Feb; 241(3):375-391. PubMed ID: 27861902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New ESMO scale ranks mutations as cancer medicine targets.
    Fricker J
    Lancet Oncol; 2018 Oct; 19(10):e513. PubMed ID: 30177495
    [No Abstract]   [Full Text] [Related]  

  • 27. Single cell genomics reveals activation signatures of endogenous SCAR's networks in aneuploid human embryos and clinically intractable malignant tumors.
    Glinsky GV
    Cancer Lett; 2016 Oct; 381(1):176-93. PubMed ID: 27497790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in breast cancer research impacting clinical diagnostic practice.
    McCart Reed AE; Kalita-De Croft P; Kutasovic JR; Saunus JM; Lakhani SR
    J Pathol; 2019 Apr; 247(5):552-562. PubMed ID: 30426489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathology in real time.
    Ryška A
    Cancer Metastasis Rev; 2016 Mar; 35(1):129-40. PubMed ID: 26931654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
    Lim B; Kim JH; Kim M; Kim SY
    World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uncovering Hereditary Tumor Syndromes: Emerging Role of Surgical Pathology.
    Agaimy A; Hartmann A
    Semin Diagn Pathol; 2018 May; 35(3):154-160. PubMed ID: 29395463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances and opportunities in proteomic analyses of tumour heterogeneity.
    Bateman NW; Conrads TP
    J Pathol; 2018 Apr; 244(5):628-637. PubMed ID: 29344964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic profiling guides the choice of molecular targeted therapy of pancreatic cancer.
    Frank TS; Sun X; Zhang Y; Yang J; Fisher WE; Gingras MC; Li M
    Cancer Lett; 2015 Jul; 363(1):1-6. PubMed ID: 25890222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic approaches to accelerate cancer interception.
    Beane J; Campbell JD; Lel J; Vick J; Spira A
    Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of a Precision Pathology Program Focused on Oncology-Based Prognostic and Predictive Outcomes.
    Donovan MJ; Cordon-Cardo C
    Mol Diagn Ther; 2017 Apr; 21(2):115-123. PubMed ID: 28000172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion genes and their discovery using high throughput sequencing.
    Annala MJ; Parker BC; Zhang W; Nykter M
    Cancer Lett; 2013 Nov; 340(2):192-200. PubMed ID: 23376639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.
    Andrews MC; Reuben A; Gopalakrishnan V; Wargo JA
    Front Immunol; 2018; 9():946. PubMed ID: 29780391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image-based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno-oncology Biomarker Working Group on Breast Cancer.
    Jahangir CA; Page DB; Broeckx G; Gonzalez CA; Burke C; Murphy C; Reis-Filho JS; Ly A; Harms PW; Gupta RR; Vieth M; Hida AI; Kahila M; Kos Z; van Diest PJ; Verbandt S; Thagaard J; Khiroya R; Abduljabbar K; Acosta Haab G; Acs B; Adams S; Almeida JS; Alvarado-Cabrero I; Azmoudeh-Ardalan F; Badve S; Baharun NB; Bellolio ER; Bheemaraju V; Blenman KR; Botinelly Mendonça Fujimoto L; Burgues O; Chardas A; Cheang MCU; Ciompi F; Cooper LA; Coosemans A; Corredor G; Dantas Portela FL; Deman F; Demaria S; Dudgeon SN; Elghazawy M; Fernandez-Martín C; Fineberg S; Fox SB; Giltnane JM; Gnjatic S; Gonzalez-Ericsson PI; Grigoriadis A; Halama N; Hanna MG; Harbhajanka A; Hart SN; Hartman J; Hewitt S; Horlings HM; Husain Z; Irshad S; Janssen EA; Kataoka TR; Kawaguchi K; Khramtsov AI; Kiraz U; Kirtani P; Kodach LL; Korski K; Akturk G; Scott E; Kovács A; Laenkholm AV; Lang-Schwarz C; Larsimont D; Lennerz JK; Lerousseau M; Li X; Madabhushi A; Maley SK; Manur Narasimhamurthy V; Marks DK; McDonald ES; Mehrotra R; Michiels S; Kharidehal D; Minhas FUAA; Mittal S; Moore DA; Mushtaq S; Nighat H; Papathomas T; Penault-Llorca F; Perera RD; Pinard CJ; Pinto-Cardenas JC; Pruneri G; Pusztai L; Rajpoot NM; Rapoport BL; Rau TT; Ribeiro JM; Rimm D; Vincent-Salomon A; Saltz J; Sayed S; Hytopoulos E; Mahon S; Siziopikou KP; Sotiriou C; Stenzinger A; Sughayer MA; Sur D; Symmans F; Tanaka S; Taxter T; Tejpar S; Teuwen J; Thompson EA; Tramm T; Tran WT; van der Laak J; Verghese GE; Viale G; Wahab N; Walter T; Waumans Y; Wen HY; Yang W; Yuan Y; Bartlett J; Loibl S; Denkert C; Savas P; Loi S; Specht Stovgaard E; Salgado R; Gallagher WM; Rahman A
    J Pathol; 2024 Mar; 262(3):271-288. PubMed ID: 38230434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.